The Board approved the audited financial results for the quarter and financial year ended 31st March, 2025. No dividend was recommended.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chennai Meenakshi Multispeciality Hospital reported a full-year net loss of ₹137.37 lakhs in FY25, widening from a loss of ₹42.74 lakhs in FY24. Total income fell about 7.8% to ₹3,567.21 lakhs from ₹3,867.50 lakhs, with revenue from operations declining roughly 8.9% to ₹3,481.85 lakhs. Q4 FY25 swung to a small profit of ₹31.29 lakhs from a loss in the year-ago quarter. The Board did not recommend any dividend for FY25. The auditor (Elias George & Co.) issued an unmodified opinion on the results, but the balance sheet shows negative total equity of ₹(188.73) lakhs and reserves of ₹(935.62) lakhs, while long-term borrowings stand at ₹1,062.64 lakhs.
Negative shareholders' equity, widening losses, and revenue contraction are serious red flags for a small hospital company — the stock may stay under pressure despite the clean audit opinion. With losses mounting and no dividend, existing shareholders face continued erosion of book value and limited near-term recovery signals.